The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Mastering oral solid dose (OSD) development requires strategic foresight and a clear focus on four key pillars: technology and expertise, global networks, customized services, and regulatory excellence.
These pillars provide the foundation for navigating the complexities of oral drug development, addressing challenges early, and delivering innovative therapies to patients efficiently and effectively.
This paper examines how these four pillars work together to overcome the challenges of oral drug development. By integrating in silico modeling tools, leveraging global CDMO capabilities across formulation, process development, and commercial manufacturing, and maintaining high-quality standards, development teams can streamline processes, mitigate risks, and confidently meet evolving market demands.
Key drivers of success include:
- Predictive tools and expertise drive early problem-solving and process optimization
- A global network ensures scalability, compliance, and consistent quality across regions
- Customized services adapt to the unique demands of each program and to evolving requirements at each development stage
- Proactive quality and regulatory strategies reduce risks and enable market access
